Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001206 · ClinicalTrials.gov registry record

Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)

A clinical trial of Attention Deficit Disorder With Hyperactivity and Attention Deficit and Disruptive Behavior Disorder, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
347
Enrollment target
1
Study location

NCT00001206 is a study of Attention Deficit Disorder With Hyperactivity and Attention Deficit and Disruptive Behavior Disorder that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 347 participants, roughly in line with the 338-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001206, a study of Attention Deficit Disorder With Hyperactivity and Attention Deficit and Disruptive Behavior Disorder, has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
347 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate individuals with Attention Deficit/Hyperactivity Disorder (ADHD) to learn more about the genetics of the disease. This study is part of other ongoing studies of individuals with ADHD. The study participants have already undergone neurobiological measurements, particularly magnetic resonance imaging (MRI) of the brain, through other research studies. As a follow-up to these studies, participants will next undergo psychiatric interviews, neuropsychological tests, and another MRI. In addition to the clinical evaluation of the participants, further research will be conducted on the genetics of ADHD. These genetic studies will evaluate people with ADHD as well as their family members and a control group of healthy people.

Conditions Studied

Attention Deficit Disorder With Hyperactivity Attention Deficit and Disruptive Behavior Disorder

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 347 participants
Start Date 1985-06-05
Est. Completion 2017-05-15

Sponsor

National Institute of Mental Health (NIMH)

343 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00001206

The ClinicalTrials.gov registry entry for NCT00001206 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 347 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 338-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 0 interventions.

NCT00001206 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00001206 about?

NCT00001206 is a clinical study titled "Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)". The purpose of this study is to evaluate individuals with Attention Deficit/Hyperactivity Disorder (ADHD) to learn more about the genetics of the disease. This study is part of other ongoing studies of individuals with ADHD. The study participants have already undergone neurobiological measurements...

What is the current status of trial NCT00001206?

This trial is currently completed. The enrollment target is 347 participants. The study started on 1985-06-05. Estimated completion is 2017-05-15.

What conditions does trial NCT00001206 study?

This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity, Attention Deficit and Disruptive Behavior Disorder.

Who is sponsoring clinical trial NCT00001206?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001206 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Disorder With Hyperactivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Disorder With Hyperactivity

All registered trials for this condition

Attention Deficit and Disruptive Behavior Disorder

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.